Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy
- 26 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Radiology
- Vol. 50 (9), 1277-1283
- https://doi.org/10.1007/s00247-020-04717-x
Abstract
Background Intrathecal and intravenous chemotherapy, specifically methotrexate, might contribute to neural microstructural damage. Objective To assess, by diffusion tensor imaging, microstructural integrity of white matter in paediatric patients with acute lymphoblastic leukaemia (ALL) following intrathecal and intravenous chemotherapy. Materials and methods Eleven children diagnosed with de novo ALL underwent MRI scans of the brain with diffusion tensor imaging (DTI) prior to commencement of chemotherapy and at 12 months after diagnosis, using a 3-tesla (T) MRI scanner. We investigated the changes in DTI parameters in white matter tracts before and after chemotherapy using tract-based spatial statistics overlaid on the International Consortium of Brain Mapping DTI-81 atlas. All of the children underwent formal neurodevelopmental assessment at the two study time points. Results Whole-brain DTI analysis showed significant changes between the two time points, affecting several white matter tracts. The tracts demonstrated longitudinal changes of decreasing mean and radial diffusivity. The neurodevelopment of the children was near compatible for age at the end of ALL treatment. Conclusion The quantification of white matter tracts changes in children undergoing chemotherapy showed improving longitudinal values in DTI metrics (stable fractional anisotropy, decreasing mean and radial diffusivity), which are incompatible with deterioration of microstructural integrity in these children.Keywords
Funding Information
- Universiti Malaya (RP003A-13HTM)
This publication has 28 references indexed in Scilit:
- Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic reviewNeuroscience & Biobehavioral Reviews, 2015
- Neurocognitive Outcomes Decades After Treatment for Childhood Acute Lymphoblastic Leukemia: A Report From the St Jude Lifetime Cohort StudyJournal of Clinical Oncology, 2013
- Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013The Lancet Oncology, 2013
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Minimal Residual Disease–Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 StudyJournal of Clinical Oncology, 2012
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationThe New England Journal of Medicine, 2009
- Long-Term Survivors of Childhood Cancers in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: A critical review of the literaturePediatric Blood & Cancer, 2008
- Acute lymphoblastic leukaemiaThe Lancet, 2008